vs

Side-by-side financial comparison of Baxter International (BAX) and Carlyle Group Inc. (CG). Click either name above to swap in a different company.

Baxter International is the larger business by last-quarter revenue ($2.7B vs $1.9B, roughly 1.4× Carlyle Group Inc.). Carlyle Group Inc. runs the higher net margin — 18.8% vs -0.6%, a 19.4% gap on every dollar of revenue. On growth, Carlyle Group Inc. posted the faster year-over-year revenue change (84.1% vs 3.0%). Baxter International produced more free cash flow last quarter ($76.0M vs $-1.2B). Over the past eight quarters, Carlyle Group Inc.'s revenue compounded faster (66.2% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

The Carlyle Group Inc. is an American multinational company with operations in private equity, alternative asset management and financial services. As of 2023, the company had $426 billion of assets under management.

BAX vs CG — Head-to-Head

Bigger by revenue
BAX
BAX
1.4× larger
BAX
$2.7B
$1.9B
CG
Growing faster (revenue YoY)
CG
CG
+81.1% gap
CG
84.1%
3.0%
BAX
Higher net margin
CG
CG
19.4% more per $
CG
18.8%
-0.6%
BAX
More free cash flow
BAX
BAX
$1.3B more FCF
BAX
$76.0M
$-1.2B
CG
Faster 2-yr revenue CAGR
CG
CG
Annualised
CG
66.2%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BAX
BAX
CG
CG
Revenue
$2.7B
$1.9B
Net Profit
$-15.0M
$358.1M
Gross Margin
33.0%
Operating Margin
2.4%
24.3%
Net Margin
-0.6%
18.8%
Revenue YoY
3.0%
84.1%
Net Profit YoY
69.8%
EPS (diluted)
$-0.03
$0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
CG
CG
Q1 26
$2.7B
Q4 25
$3.0B
$1.9B
Q3 25
$2.8B
$332.7M
Q2 25
$2.8B
$1.6B
Q1 25
$2.6B
$973.1M
Q4 24
$533.0M
$1.0B
Q3 24
$2.7B
$2.6B
Q2 24
$3.8B
$1.1B
Net Profit
BAX
BAX
CG
CG
Q1 26
$-15.0M
Q4 25
$-1.1B
$358.1M
Q3 25
$-46.0M
$900.0K
Q2 25
$91.0M
$319.7M
Q1 25
$126.0M
$130.0M
Q4 24
$-512.0M
$210.9M
Q3 24
$140.0M
$595.7M
Q2 24
$-314.0M
$148.2M
Gross Margin
BAX
BAX
CG
CG
Q1 26
33.0%
Q4 25
19.4%
Q3 25
33.5%
Q2 25
35.3%
Q1 25
32.8%
Q4 24
25.0%
Q3 24
38.3%
Q2 24
37.5%
Operating Margin
BAX
BAX
CG
CG
Q1 26
2.4%
Q4 25
-24.5%
24.3%
Q3 25
6.1%
25.8%
Q2 25
6.8%
28.0%
Q1 25
2.2%
17.6%
Q4 24
-25.5%
25.7%
Q3 24
5.7%
29.9%
Q2 24
-5.0%
20.5%
Net Margin
BAX
BAX
CG
CG
Q1 26
-0.6%
Q4 25
-37.9%
18.8%
Q3 25
-1.6%
0.3%
Q2 25
3.2%
20.3%
Q1 25
4.8%
13.4%
Q4 24
-96.1%
20.4%
Q3 24
5.2%
22.6%
Q2 24
-8.2%
13.9%
EPS (diluted)
BAX
BAX
CG
CG
Q1 26
$-0.03
Q4 25
$-2.21
$0.96
Q3 25
$-0.09
$0.00
Q2 25
$0.18
$0.87
Q1 25
$0.25
$0.35
Q4 24
$-0.99
$0.56
Q3 24
$0.27
$1.63
Q2 24
$-0.62
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
CG
CG
Cash + ST InvestmentsLiquidity on hand
$2.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.1B
Total Assets
$29.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
CG
CG
Q1 26
Q4 25
$2.0B
$2.0B
Q3 25
$1.7B
$2.2B
Q2 25
$1.7B
$1.3B
Q1 25
$2.3B
$1.2B
Q4 24
$1.8B
$1.3B
Q3 24
$1.4B
$1.4B
Q2 24
$2.1B
$914.8M
Total Debt
BAX
BAX
CG
CG
Q1 26
Q4 25
$9.5B
Q3 25
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
CG
CG
Q1 26
Q4 25
$6.1B
$7.1B
Q3 25
$7.2B
$6.8B
Q2 25
$7.3B
$6.7B
Q1 25
$7.1B
$6.4B
Q4 24
$7.0B
$6.3B
Q3 24
$7.9B
$6.3B
Q2 24
$7.6B
$5.7B
Total Assets
BAX
BAX
CG
CG
Q1 26
Q4 25
$20.1B
$29.1B
Q3 25
$21.1B
$27.1B
Q2 25
$21.0B
$25.1B
Q1 25
$21.3B
$24.1B
Q4 24
$25.8B
$23.1B
Q3 24
$26.7B
$22.7B
Q2 24
$26.3B
$22.3B
Debt / Equity
BAX
BAX
CG
CG
Q1 26
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
CG
CG
Operating Cash FlowLast quarter
$-1.2B
Free Cash FlowOCF − Capex
$76.0M
$-1.2B
FCF MarginFCF / Revenue
2.8%
-65.1%
Capex IntensityCapex / Revenue
5.1%
2.2%
Cash ConversionOCF / Net Profit
-3.34×
TTM Free Cash FlowTrailing 4 quarters
$-3.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
CG
CG
Q1 26
Q4 25
$584.0M
$-1.2B
Q3 25
$237.0M
$-1.6B
Q2 25
$217.0M
$-168.8M
Q1 25
$-193.0M
$-352.1M
Q4 24
$488.0M
$-352.8M
Q3 24
$253.0M
$791.9M
Q2 24
$115.0M
$-1.3B
Free Cash Flow
BAX
BAX
CG
CG
Q1 26
$76.0M
Q4 25
$-1.2B
Q3 25
$-1.6B
Q2 25
$-186.3M
Q1 25
$-368.8M
Q4 24
$-379.5M
Q3 24
$772.8M
Q2 24
$-1.3B
FCF Margin
BAX
BAX
CG
CG
Q1 26
2.8%
Q4 25
-65.1%
Q3 25
-475.7%
Q2 25
-11.8%
Q1 25
-37.9%
Q4 24
-36.8%
Q3 24
29.3%
Q2 24
-120.4%
Capex Intensity
BAX
BAX
CG
CG
Q1 26
5.1%
Q4 25
2.2%
Q3 25
7.0%
Q2 25
1.1%
Q1 25
1.7%
Q4 24
2.6%
Q3 24
0.7%
Q2 24
1.7%
Cash Conversion
BAX
BAX
CG
CG
Q1 26
Q4 25
-3.34×
Q3 25
-1732.78×
Q2 25
2.38×
-0.53×
Q1 25
-1.53×
-2.71×
Q4 24
-1.67×
Q3 24
1.81×
1.33×
Q2 24
-8.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAX
BAX

Segment breakdown not available.

CG
CG

Fund Management Fee$606.8M32%
Other$528.7M28%
Global Private Equity Segment$307.3M16%
Global Credit Segment$238.0M13%
Carlyle Alp Invest Segment$124.6M7%
Incentive Fee$55.4M3%
Fee Related Performance Revenues$29.2M2%
Investment Advice$11.1M1%

Related Comparisons